FDA approves First motion sickness drug in over 40 years
Digest more
The U.S. Food and Drug Administration has declined to approve Corcept Therapeutics' drug for the treatment of a rare hormonal ...
Louisiana argues the FDA’s rule directly interferes with its ability to enforce those laws by facilitating the mailing of ...
The FDA has issued a complete response letter for an oral selective glucocorticoid receptor antagonist under investigation ...
The FDA gave its decision despite acknowledging Corcept's trial having met its primary endpoint and that data from another trial provided confirmatory evidence. Chief Executive Joseph Belanoff said ...
FDA rejects cortisol modulator for hypertension, citing need for additional data despite trial success, delaying approval for Corcept ...
The FDA has approved Deseyne contact lenses with extended depth of focus for the correction of presbyopia, according to a ...
MedPage Today on MSN
Five Leaders in One Year: FDA's Drug Center Enters 2026 at a Crossroads
The FDA appointed George Tidmarsh, MD, PhD, to be the nation's top drug official in July. The Center for Drug Evaluation and ...
The FDA has approved the first GLP-1 pill for weight loss and it's expected in pharmacies in the coming weeks. Dr. Holly ...
The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary ...
The FDA has announced a recall of frozen raw shrimp due to potential exposure to the radioactive isotope cesium-137. The FDA ...
Merck & Co., Inc. (NYSE:MRK) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 17, the US Food ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results